DrugDashboards

Market view

infliximab-axxq · Injection, Powder, Lyophilized, For Solution

2 marketed package NDCs · 1 active manufacturer

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

Same drug class

Other molecules FDA puts in Tumor Necrosis Factor Blocker, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Infliximab-axxq in shortage right now?
No. FDA does not currently list Infliximab-axxq in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Infliximab-axxq?
1 company has marketed Infliximab-axxq in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.